Patent application number | Description | Published |
20110318434 | Acne Vulgaris Treatment Regimen - An improved method, formulation and kit for the treatment of acne vulgaris are disclosed. The formulation is effective in inhibiting or killing the | 12-29-2011 |
20120135529 | Detection of Occult Blood in Feces or Urine - The present invention relates to an improved method, reagents and kit for the detection of fecal or urine occult blood. The reagents are either supplied as solutions in small vials or incorporated into a matrix that is treated, impregnated, or imprinted with the test reagents that are capable of undergoing a chromagenic reaction. The method elucidates false positives from dietary sources, oxidants in the toilet water supply and is specific for blood. A stabilized chromogenic solution is disclosed which contains phemolphthalin in a deoxygenated, basic solution. The chromagenic solution either in a liquid or matrix form is placed into the toilet water following urination or defecation. A few moments are allowed to occur for observation of the matrix turning from colorless to a hot-pink. A hot pink color is indicative of a false positive. If no color change occurs, an oxidizing solution is added to the toilet water. If a change from colorless to a hot-pink occurs in less than thirty seconds then this test is positive and specific for occult blood in this fecal and/or urine specimen. Typically, the oxidizing solution is hydrogen peroxide. Hemoglobin or a porphyrin solution can be added to a separate matrix or | 05-31-2012 |
20120178731 | NASAL, WOUND AND SKIN FORMULATIONS AND METHODS FOR CONTROL OF ANTIBIOTIC-RESISTANT STAPHYLOCOCCI AND OTHER GRAM-POSITIVE BACTERIA - Formulations and methods are disclosed which are effective to kill or control bacteria in the nares including gram-positive bacteria strains of | 07-12-2012 |
20120207688 | Rosacea Topical Skin Treatment Method and Formulation - A method for topical treatment of rosacea comprising application of a formulation to the affected area is disclosed. The formulation comprises one or more iron chelators. Omadine, a bispyrithione salt, and kojic acid are the preferred iron chelators. The formulation also comprises one or more false substrates for arachidonic acid. The preferred false substrates for arachidonic acid are alpha-linoleic acid and gamma dihomo-linolenic acid. The formulation further comprises an inhibitor of stratum corneum tryptic enzyme (SCTE). A preferred stratum corneum tryptic enzyme inhibitor is zinc. The formulation also preferably includes one or more medium-chain saturated fatty acid monoester. The preferred medium-chain fatty acid monoesters are glycerol monolaurate and glycerol monocaprylate. Formulation components are solubilized in a suitable carrier base which includes emollient, humectant, antioxidant and sunscreen components. The method preferably comprises application of a leave-on formulation. Alternatively, a pre-step of application of a rinse-off formulation containing a higher concentration of an iron chelator may be employed in the regimen. | 08-16-2012 |
20130289005 | Acne Vulgaris Treatment Regimen - A kit for treatment of acne vulgaris, said formulation of the kit effectively inhibiting or killing | 10-31-2013 |